Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Serotonin & Their antagonists

Serotonin is major neurotransmitter and affects the physiology of our body. Serotonin antagonists are used in various pathological conditions of body. This is a small presentation showing feature of serotonin.

  • Be the first to comment

Serotonin & Their antagonists

  1. 1. SEROTONIN & THEIR ANTAGONISTS By Rajneesh Kumar Singh M.Pharm. (Pharmacology)
  2. 2. SEROTONIN Serotonin is a naturally occurring amine synthesized from the tryptophan & commonly found in plants ,some fruits ,animal tissues & insect venoms. In human being , it is found in enterochromaffin cells in g.i.t & CNS . Serotonin containing neurons are mainly found in limbic system, raphae nucleus, cortex, hypothalamus, amygdala, caudal nucleus , mid –brain, vomiting centre & spinal cord . These regulate sleep, body temperature & mood . A hormone melatonin is derived from serotonin .
  3. 3. SYNTHESIS AND DEGRADATION
  4. 4. PHARMACOLOGICAL ACTIONS OF SEROTONIN (5-HT) • Action on GIT  5-HT act as a local hormone & to regulate peristelsis movement. • Action on CNS  It act as neurotransmitter in CNS • Action on CVS  5-HT produces positive ionotropic EFFECT & chromotropic effect in myocardium . • Action on smooth muscles  5-HT constrict the smooth muscles of bronchia and GIT .
  5. 5. PHARMACOLOGICAL ACTIONS Action on blood vessels  5-HT dilate the blood vessels of skeletal muscles, coronary arteries & capillary of skin . Action on platelets  It enhance the aggregation of platelets & haemostatis.
  6. 6. DEPRESSION  Possible problems include low brain cell production of serotonin, a lack of receptor sites able to receive the serotonin that is made, inability of serotonin to reach the receptor sites, or a shortage in tryptophan, the chemical from which serotonin is made.  If any of these biochemical glitches occur, researchers believe it can lead to depression, as well as obsessive- compulsive disorder, anxiety, panic, and
  7. 7. 5-HT RECEPTORS  The 5-HT receptors are the receptors for serotonin. They are located on the cell membrane of nerve cells and other cell types in animals, and mediate the effects of serotonin as the endogenous ligand.  With the exception of the 5-HT3 receptor, a ligand-gated ion channel, all other 5-HT receptors are G protein- coupled, seven transmembrane(or heptahelical) receptors that activate an intracellular second messenger cascade.
  8. 8. 5-HT Receptors  5-HT1-receptors occur mainly in CNS (all subtypes) and some blood vessels (5-HT1D subtype).  Effects are neural inhibition and vasoconstriction. Act by inhibiting adenylate cyclase.
  9. 9.  5-HT2-receptors occur in CNS and many peripheral sites (especially blood vessels, platelets, autonomic neurons). Neuronal and smooth muscle effects are excitatory. Some blood vessels dilated as a result of nitric oxide release from endothelial cells. 5-HT2- receptors acts through phospholipase C/inositol trisphosphate pathway.  5-HT3-receptors occur in peripheral nervous system, especially nociceptive afferent neurons and enteric neurons, and in CNS. Effects are excitatory, mediated via direct receptor-coupled ion channel.
  10. 10.  5-HT4-receptors occur mainly in the enteric nervous system (also in CNS). Effects are excitatory, causing increased gastrointestinal motility. Act by stimulating adenylate cyclase.  Little is known so far about the function and pharmacology of 5-HT5-7- receptors.
  11. 11. MECHANISM OF ACTION  5-HT1A receptor-induced membrane hyperpolarization and reduction in input resistance results from an increase in K+ conductance.  Slow depolarization induced by 5-HT2A- receptor activation in areas such as the prefrontal cortex, nucleus accumbens, and facial motor nucleus involves a decrease in K+ conductance.  A second, distinct mechanism involving Ca2+- activated membrane currents enhances neuronal excitability and potentiates the response to excitatory signals such as glutamate.
  12. 12.  The fast depolarization elicited by 5- HT3 receptors reflects direct gating of an ion channel intrinsic to the receptor structure itself.  The 5-HT3 receptor-induced inward current has the characteristics of a cation-selective, ligand-operated channel. Membrane depolarization is mediated by simultaneous increases in Na+ and K+ conductance.
  13. 13. PATHOPHYSIOLOGICAL ROLES  Neurotransmitter  Precursor of melatonin  Neuroendocrine functions  Nausea and vomiting  Migraine  Haemostasis  Hypertension  Intestinal motility etc.
  14. 14. DRUGS AFFECTING 5-HT SYSTEM  5-HT PRECURSORS: Tryptophan increase brain 5-HT & produce behavioral effects.  SYNTHESIS INHIBITORS p-Chlorophenylalanin selectively inhibit tryptophan hydroxylase & reduce 5-HT level in tissue .  UPTAKE INHIBITORS Tricyclic antidepressants inhibit 5-HT uptake along with NA .Some like fluoxetine ,sertraline are selective serotonin reuptake inhibitors.
  15. 15.  STORAGE INHIBITORS Reserpine block 5-HT uptake into storage granules & cause depletion of all cell monoamines .  DEGRADATION INHIBITORAS Non-selective MAO inhibitors (tranylcypromine) &selective MAO –A inhibitors (chlorgyline) increase 5-HT content by preventing its degradation.  NEURONAL DEGENRATION 5,6 Dihydroxytryptamine selectively destroys 5-HT neurons .
  16. 16. 5-HT RECEPTIR AGONISTS 1. D-Lysergic acid diethyl amide(LSD)  Non selective 5-HT agonist  Activates subtypes of 5-HT receptors including 5-HT1A, 5HT2A/2C ,5HT5-7 .  Antagonize 5HT2A receptor in ileum . AZAPIRONES  Like buspirons ,gepirone act as partial agonist of 5HT1A Receptor in brain. 8 HYDROXYDIPROPYLAMINO TETRALINE  Selective 5HT1A agonist  Used as experimental tool
  17. 17.  SUMATRIPTAN AND OTHER TRIPTAN Selective 5HT1B/1D agonists, Most effective in treatment of acute migraine attack  CISAPRIDE Prokinetic drug increase g.i.t motility Selective 5HT4 agonist.  M-Cholorophenylpiperazine Active metabolite of antidepressant drug TRAZODONE. found to be agonist of 5HT1B 5HT2A/2C Receptor in brain.
  18. 18. 5-HT RECEPTOR ANTAGONISTS  Cyproheptadine  Methysergide  Ketanserin  Clozapine  Risperidone  Ondansetron
  19. 19. CYPROHEPTADINE Block 5HT2A receptor Utilized in controlling intestinal manifestations of carcinoid & postgastrectomy dumping syndrome Antagonize priapism caused by 5HT uptake inhibitor like fluoxetine. Side effects: drowsiness,dry mouth ,ataxia confusion.
  20. 20. METHYSERGIDE Antagonize action of 5HT on smooth muscles including that of blood vessels Potent 5HT2A/2C ANTAGONIST & Non selectively act on 5HT1 receptors . Used for migraine prophylaxis
  21. 21. RISPERIDONE 5HT2A antagonist Ameliorates negative symptoms of schipherenia Produce extrapyramidal side effects on slightly higher doses
  22. 22. ONDANSETRON Selectively 5HT3 Antagonist Remarkable efficacy in controlling nausea & vomiting following administration of highly emetic anticancer drugs & radiotherapy .
  23. 23. KETANSERIN Selective 5HT2 receptor blocking property with action on 5HT1,5HT3 & 5HT4 receptors . 5HT induced vasoconstriction ,platelets aggregation & contraction of airway smooth muscles are antagonized but not contraction of guinea pig ileum or rat stomach .
  24. 24. CLOZAPINE 5HT2A/2C blocker Inverse agonist activity at cerebral 5HT2A/2C Receptors Efficacy in resistant cases of schizophrenia
  25. 25.  Goodman & Gilman’s “The Pharmacological basis of Therapeutics” Eleventh Edition, 2001. Published By McGraw- Hill Publishing Company.  “Tripathi K D”; “Essential of Medical Pharmacology”; Fifth edition 2003, Published by Jaypee Brothers .  “Rang H P”, “Dale M M”, “Ritter J M”, “Flower R J”; “Rang and Dale’s Pharmacology”; Sixth edition, Published by Churchchill Livingstone. REFRENCES
  26. 26.  GOODMAN & GILMAN'S “THE PHARMACOLOGICAL BASIS OF THERAPEUTICS”, Eleventh Edition, 2001. Published By McGraw-Hill Publishing Company  Tripathi K..D , ”Essentials of Medical Pharmacology”, 6th Edition 2010, Published By : Jaypee Medical Publishers  RANG H.P, DALE M.M, RITTER.J, FLOWER.R,” Rang & Dales Pharmacology, Sixth Edition 2010. Published By : Churchill Livingstone.

×